卵巢上皮癌初次治疗方式对预后的影响  

Effect of treatment modality on prognosis in epithelial ovarian carcinoma

作　　者：田丽英 金玉芹[2] 

机构地区：[1]山东省郓城县人民医院妇产科,山东郓城274700 [2]山东省肿瘤医院妇瘤科,山东济南250117

出　　处：《中华肿瘤防治杂志》2009年第18期1430-1431,共2页Chinese Journal of Cancer Prevention and Treatment

摘　　要：为了探讨不同治疗方法对上皮性卵巢癌预后的影响,回顾性分析78例初治上皮性卵巢癌患者的临床资料。所有患者随访至2009-01,5年生存率为45.0%(18/40),3年生存率为63.2%(36/57);残余病灶<2cm者3年和5年生存率分别为69.4%和48.4%,残余病灶>2cm者分别为38.5%和0;无腹水患者3、5年生存率高于合并腹水者>20%。回顾性分析结果提示,手术后有无残余病灶、残余病灶大小及有无腹水是影响卵巢癌患者预后的主要因素,手术方式的选择、腹膜后淋巴结清除对预后影响不显著。The objective of the study was to evaluate the effect on prognosis of different treatments in patients with epithelial ovarian carcinoma. The clinical data of 78 patients with epithelial ovarian carcinoma were retrospectively analyzed. Following up to Jan. 2009,the total 3-year and 5-year survival rates were 63.2%（36/57） and 45.0%（18/40）,respectively. The 3-year and 5-year survival rates of patients whose residual diseases were smaller than 2 cm were 69.4% and 48.4%,respectively. The 3-year survival rate of patients whose residual diseases were bigger than 2 cm was 38.5%,and the 5-year survival rate was 0. The 3-year and 5-year survival rates in patients without ascites were higher above 20% than those in patients with ascites. In conclusion,the residual disease after the operation,the size of residual disease and ascites are the major prognostic factors. The effects of surgical modality and lymphadenectomy on prognosis are not significant.

关 键 词：卵巢肿瘤/外科学 回顾性研究 预后 

分 类 号：R737.31[医药卫生—肿瘤]